CEO
Epitracker Inc.
Stephanie Venn-Watson, DVM, MPH is a veterinary epidemiologist and public health scientist with over 50 patents and 70 peer-reviewed scientific publications. Her novel approach to discovering molecules that support healthy aging in long-lived mammals has been featured by NPR Science Friday, BBC, the New York Times, and National Geographic. Currently serving as co-founder and CEO of Epitracker Inc. and Seraphina Therapeutics, Stephanie previously served as an epidemiologist for the U.S. Navy, Centers for Disease Control and Prevention, and World Health Organization. She has been awarded the Department of Health and Human Services' Secretary's Award for Health Promotion and Disease Prevention and is an Albert Schweitzer Fellow for Life. Stephanie received her D.V.M. from Tufts University School of Veterinary Medicine, M.P.H. from Rollins School of Public Health at Emory University, and B.S. in Animal Physiology and Neurosciences from the University of California, San Diego.